No Data
No Data
Top Gap Ups and Downs on Friday: IX, TTWO, EXPE and More
European Equities Traded in the US as American Depositary Receipts Rise Friday
Top Gap Ups and Downs on Thursday: LLY, PH, MCK and More
Guolian Securities: Increased attention to tumor immunology, recommend focusing on targeted drugs such as PD1/IL2 in pharmaceutical companies.
With the increasing attention to tumor immunity, and the successive launch of advantageous products, bullish on PD1/IL2 and PD1/IL15 targeted drugs.
Novartis Says FDA Gives Accelerated Approval for Kidney-Disease Treatment
Novartis Receives FDA Accelerated Approval for Fabhalta (Iptacopan), the First and Only Complement Inhibitor for the Reduction of Proteinuria in Primary IgA Nephropathy (IgAN)